ISCT 2020: emerging issues in unproven cell therapies – an interview with Laertis Ikonomou


ISCT 2020: emerging issues in unproven cell therapies – an interview with Laertis Ikonomou

In this interview, conducted at the International Society of Cell and Gene Therapy (ISCT) Virtual Conference (28–29 May 2020), Laertis Ikonomou (University at Buffalo, NY, USA), Chair, ISCT Presidential Task Force (PTF) on the Use of Unproven and/or Unethical Cell and Gene Therapy, explores the evolving field of cell therapy regulation and discusses the need for widespread education on the risks associated with unproven cell therapies. How did you get involved in the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell and Gene Therapy (PTF)? I am a stem cell biologist, working with embryonic and induced...

To view the full article, please register now for access

It's completely free